ReviewAntonie van Leeuwenhoek2026
Mediterranean diet, gut microbiota, and intestinal barrier integrity: implications for digestive and systemic health.
Review in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Mediterranean diet has gained increasing attention for its effects on gut microbiota, microbial metabolism, intestinal barrier function, and related clinical outcomes. This narrative review critically synthesizes evidence from 51 publications identified through structured searches of PubMed/MEDLINE and Google Scholar, including human intervention studies, observational studies, systematic and narrative reviews, and selected preclinical studies. The available evidence suggests that the MD can influence microbial composition and function, although taxonomic responses vary considerably between populations and study designs. More consistent findings involve microbial metabolic activity, particularly short-chain fatty acid production, bile acid remodeling, and polyphenol-derived metabolites. These changes may contribute to intestinal barrier regulation, mucosal homeostasis, and immune modulation. Human intervention studies provide supportive evidence in inflammatory bowel disease, functional gastrointestinal disorders, obesity, metabolic syndrome, and related conditions, while evidence for neurological, autoimmune, and cancer-related outcomes remains more limited and is often observational or mechanistic. Direct evidence for improved intestinal barrier function is still less extensive than indirect evidence based on inflammatory markers, microbial metabolites, and permeability-related measures. Differences in microbiome methodology, baseline diet, disease status, geographic background, and intervention duration contribute to variability across studies. The MD therefore represents a promising dietary framework for modulating gut microbial function and intestinal homeostasis, but further long-term and mechanistically integrated human studies are needed to define causal pathways and identify individuals most likely to benefit.
Indexed as
Identifiers
42867711What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.